|
|
Presentation
|
|
|
About us
Specialising in clinical research, epidemiology and public health interventions, Kappa Santé is a limited company with assets of 50 k€. The shareholders are as follows: Dr Stéphane SCHÜCK: Chairman of the Board
Stéphane Schück, co-founder of Kappa Santé, leads the scientific aspect of the business. A doctor of medicine and former resident in public health (Université de Rennes I), Stéphane Schück trained in clinical pharmacology (Université de Rennes I) and epidemiology [postgraduate diploma (DEA) in epidemiology and public health interventions, Bordeaux].
Stéphane Schück has been conducting therapeutic trials and pharmacoepidemiological studies since 1993, and has an extensive experience in the field of central nervous system medicinal products. He worked as a project manager, then medical director in market research firms dedicated to the pharmaceutical industry and healthcare institutions.
Nathalie Texier – Project DirectorNathalie Texier, pharmacist with a diploma in epidemiology, coordinates all of the projects: manages resources; ensures operational implementation of projects; ensures that the documents relative to the projects comply with regulatory and legislative requirements; ensures that the specifications and contract are adhered to; draws up operating procedures in collaboration with the quality manager.
Tel.: +33 (0)1 44 82 74 73
email: nathalie.texier@kappasante.com
|
|
|
|
| | |